nodes	percent_of_prediction	percent_of_DWPC	metapath
Polythiazide—Cutaneous vasculitis—Tamoxifen—pancreatic cancer	0.0789	0.0789	CcSEcCtD
Polythiazide—Vasculitis—Tamoxifen—pancreatic cancer	0.0211	0.0211	CcSEcCtD
Polythiazide—Hyperuricaemia—Sunitinib—pancreatic cancer	0.019	0.019	CcSEcCtD
Polythiazide—Blood uric acid increased—Sunitinib—pancreatic cancer	0.018	0.018	CcSEcCtD
Polythiazide—Vasculitis—Gemcitabine—pancreatic cancer	0.0145	0.0145	CcSEcCtD
Polythiazide—Cramp muscle—Tamoxifen—pancreatic cancer	0.0135	0.0135	CcSEcCtD
Polythiazide—Pancreatitis—Tamoxifen—pancreatic cancer	0.0127	0.0127	CcSEcCtD
Polythiazide—Pancreatitis—Erlotinib—pancreatic cancer	0.0125	0.0125	CcSEcCtD
Polythiazide—Photosensitivity—Fluorouracil—pancreatic cancer	0.0115	0.0115	CcSEcCtD
Polythiazide—Pancreatitis—Sunitinib—pancreatic cancer	0.0109	0.0109	CcSEcCtD
Polythiazide—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00998	0.00998	CcSEcCtD
Polythiazide—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00963	0.00963	CcSEcCtD
Polythiazide—Cramp muscle—Irinotecan—pancreatic cancer	0.0095	0.0095	CcSEcCtD
Polythiazide—Pancreatitis—Irinotecan—pancreatic cancer	0.00894	0.00894	CcSEcCtD
Polythiazide—Muscle spasms—Tamoxifen—pancreatic cancer	0.00866	0.00866	CcSEcCtD
Polythiazide—Glycosuria—Epirubicin—pancreatic cancer	0.00836	0.00836	CcSEcCtD
Polythiazide—Leukopenia—Tamoxifen—pancreatic cancer	0.00806	0.00806	CcSEcCtD
Polythiazide—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00801	0.00801	CcSEcCtD
Polythiazide—Photosensitivity reaction—Fluorouracil—pancreatic cancer	0.00797	0.00797	CcSEcCtD
Polythiazide—Jaundice—Irinotecan—pancreatic cancer	0.00792	0.00792	CcSEcCtD
Polythiazide—Glycosuria—Doxorubicin—pancreatic cancer	0.00774	0.00774	CcSEcCtD
Polythiazide—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00771	0.00771	CcSEcCtD
Polythiazide—Muscle spasms—Sunitinib—pancreatic cancer	0.00741	0.00741	CcSEcCtD
Polythiazide—Agranulocytosis—Gemcitabine—pancreatic cancer	0.00739	0.00739	CcSEcCtD
Polythiazide—Hyperuricaemia—Epirubicin—pancreatic cancer	0.0073	0.0073	CcSEcCtD
Polythiazide—Agranulocytosis—Fluorouracil—pancreatic cancer	0.00727	0.00727	CcSEcCtD
Polythiazide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.0072	0.0072	CcSEcCtD
Polythiazide—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00714	0.00714	CcSEcCtD
Polythiazide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.00712	0.00712	CcSEcCtD
Polythiazide—Anorexia—Tamoxifen—pancreatic cancer	0.007	0.007	CcSEcCtD
Polythiazide—Anorexia—Erlotinib—pancreatic cancer	0.00693	0.00693	CcSEcCtD
Polythiazide—Leukopenia—Sunitinib—pancreatic cancer	0.0069	0.0069	CcSEcCtD
Polythiazide—Blood uric acid increased—Epirubicin—pancreatic cancer	0.0069	0.0069	CcSEcCtD
Polythiazide—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.00676	0.00676	CcSEcCtD
Polythiazide—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.00666	0.00666	CcSEcCtD
Polythiazide—Paraesthesia—Tamoxifen—pancreatic cancer	0.0066	0.0066	CcSEcCtD
Polythiazide—Cramp muscle—Docetaxel—pancreatic cancer	0.00657	0.00657	CcSEcCtD
Polythiazide—Decreased appetite—Tamoxifen—pancreatic cancer	0.00639	0.00639	CcSEcCtD
Polythiazide—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.00638	0.00638	CcSEcCtD
Polythiazide—Aplastic anaemia—Epirubicin—pancreatic cancer	0.00636	0.00636	CcSEcCtD
Polythiazide—Decreased appetite—Erlotinib—pancreatic cancer	0.00632	0.00632	CcSEcCtD
Polythiazide—Constipation—Tamoxifen—pancreatic cancer	0.00628	0.00628	CcSEcCtD
Polythiazide—Constipation—Erlotinib—pancreatic cancer	0.00622	0.00622	CcSEcCtD
Polythiazide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.00616	0.00616	CcSEcCtD
Polythiazide—Muscle spasms—Irinotecan—pancreatic cancer	0.00611	0.00611	CcSEcCtD
Polythiazide—Anorexia—Sunitinib—pancreatic cancer	0.006	0.006	CcSEcCtD
Polythiazide—Aplastic anaemia—Doxorubicin—pancreatic cancer	0.00589	0.00589	CcSEcCtD
Polythiazide—Urticaria—Tamoxifen—pancreatic cancer	0.00584	0.00584	CcSEcCtD
Polythiazide—Vertigo—Irinotecan—pancreatic cancer	0.00571	0.00571	CcSEcCtD
Polythiazide—Leukopenia—Irinotecan—pancreatic cancer	0.00569	0.00569	CcSEcCtD
Polythiazide—Paraesthesia—Sunitinib—pancreatic cancer	0.00565	0.00565	CcSEcCtD
Polythiazide—Photosensitivity—Epirubicin—pancreatic cancer	0.0056	0.0056	CcSEcCtD
Polythiazide—Leukopenia—Gemcitabine—pancreatic cancer	0.00554	0.00554	CcSEcCtD
Polythiazide—Vascular purpura—Epirubicin—pancreatic cancer	0.0055	0.0055	CcSEcCtD
Polythiazide—Jaundice—Docetaxel—pancreatic cancer	0.00548	0.00548	CcSEcCtD
Polythiazide—Decreased appetite—Sunitinib—pancreatic cancer	0.00547	0.00547	CcSEcCtD
Polythiazide—Leukopenia—Fluorouracil—pancreatic cancer	0.00545	0.00545	CcSEcCtD
Polythiazide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00541	0.00541	CcSEcCtD
Polythiazide—Constipation—Sunitinib—pancreatic cancer	0.00538	0.00538	CcSEcCtD
Polythiazide—Asthenia—Tamoxifen—pancreatic cancer	0.00527	0.00527	CcSEcCtD
Polythiazide—Agranulocytosis—Docetaxel—pancreatic cancer	0.00524	0.00524	CcSEcCtD
Polythiazide—Asthenia—Erlotinib—pancreatic cancer	0.00522	0.00522	CcSEcCtD
Polythiazide—Photosensitivity—Doxorubicin—pancreatic cancer	0.00518	0.00518	CcSEcCtD
Polythiazide—Purpura—Epirubicin—pancreatic cancer	0.0051	0.0051	CcSEcCtD
Polythiazide—Vascular purpura—Doxorubicin—pancreatic cancer	0.00509	0.00509	CcSEcCtD
Polythiazide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.00508	0.00508	CcSEcCtD
Polythiazide—Diarrhoea—Tamoxifen—pancreatic cancer	0.00503	0.00503	CcSEcCtD
Polythiazide—Diarrhoea—Erlotinib—pancreatic cancer	0.00497	0.00497	CcSEcCtD
Polythiazide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.00494	0.00494	CcSEcCtD
Polythiazide—Anorexia—Irinotecan—pancreatic cancer	0.00494	0.00494	CcSEcCtD
Polythiazide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.00486	0.00486	CcSEcCtD
Polythiazide—Dizziness—Tamoxifen—pancreatic cancer	0.00486	0.00486	CcSEcCtD
Polythiazide—Anorexia—Gemcitabine—pancreatic cancer	0.00481	0.00481	CcSEcCtD
Polythiazide—Dizziness—Erlotinib—pancreatic cancer	0.00481	0.00481	CcSEcCtD
Polythiazide—Anorexia—Fluorouracil—pancreatic cancer	0.00473	0.00473	CcSEcCtD
Polythiazide—Purpura—Doxorubicin—pancreatic cancer	0.00472	0.00472	CcSEcCtD
Polythiazide—Vomiting—Tamoxifen—pancreatic cancer	0.00467	0.00467	CcSEcCtD
Polythiazide—Paraesthesia—Irinotecan—pancreatic cancer	0.00466	0.00466	CcSEcCtD
Polythiazide—Hypersensitivity—Sunitinib—pancreatic cancer	0.00464	0.00464	CcSEcCtD
Polythiazide—Rash—Tamoxifen—pancreatic cancer	0.00463	0.00463	CcSEcCtD
Polythiazide—Dermatitis—Tamoxifen—pancreatic cancer	0.00463	0.00463	CcSEcCtD
Polythiazide—Vomiting—Erlotinib—pancreatic cancer	0.00462	0.00462	CcSEcCtD
Polythiazide—Headache—Tamoxifen—pancreatic cancer	0.0046	0.0046	CcSEcCtD
Polythiazide—Rash—Erlotinib—pancreatic cancer	0.00458	0.00458	CcSEcCtD
Polythiazide—Dermatitis—Erlotinib—pancreatic cancer	0.00458	0.00458	CcSEcCtD
Polythiazide—Headache—Erlotinib—pancreatic cancer	0.00455	0.00455	CcSEcCtD
Polythiazide—Paraesthesia—Gemcitabine—pancreatic cancer	0.00453	0.00453	CcSEcCtD
Polythiazide—Asthenia—Sunitinib—pancreatic cancer	0.00452	0.00452	CcSEcCtD
Polythiazide—Decreased appetite—Irinotecan—pancreatic cancer	0.00451	0.00451	CcSEcCtD
Polythiazide—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.00449	0.00449	CcSEcCtD
Polythiazide—Paraesthesia—Fluorouracil—pancreatic cancer	0.00446	0.00446	CcSEcCtD
Polythiazide—Constipation—Irinotecan—pancreatic cancer	0.00443	0.00443	CcSEcCtD
Polythiazide—Decreased appetite—Gemcitabine—pancreatic cancer	0.00439	0.00439	CcSEcCtD
Polythiazide—Nausea—Tamoxifen—pancreatic cancer	0.00437	0.00437	CcSEcCtD
Polythiazide—Constipation—Gemcitabine—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Polythiazide—Nausea—Erlotinib—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Polythiazide—Decreased appetite—Fluorouracil—pancreatic cancer	0.00432	0.00432	CcSEcCtD
Polythiazide—Diarrhoea—Sunitinib—pancreatic cancer	0.00431	0.00431	CcSEcCtD
Polythiazide—Muscle spasms—Docetaxel—pancreatic cancer	0.00422	0.00422	CcSEcCtD
Polythiazide—Pancreatitis—Epirubicin—pancreatic cancer	0.00417	0.00417	CcSEcCtD
Polythiazide—Dizziness—Sunitinib—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Polythiazide—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00416	0.00416	CcSEcCtD
Polythiazide—Vomiting—Sunitinib—pancreatic cancer	0.004	0.004	CcSEcCtD
Polythiazide—Rash—Sunitinib—pancreatic cancer	0.00397	0.00397	CcSEcCtD
Polythiazide—Dermatitis—Sunitinib—pancreatic cancer	0.00396	0.00396	CcSEcCtD
Polythiazide—Urticaria—Fluorouracil—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Polythiazide—Headache—Sunitinib—pancreatic cancer	0.00394	0.00394	CcSEcCtD
Polythiazide—Leukopenia—Docetaxel—pancreatic cancer	0.00393	0.00393	CcSEcCtD
Polythiazide—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00388	0.00388	CcSEcCtD
Polythiazide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00386	0.00386	CcSEcCtD
Polythiazide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00383	0.00383	CcSEcCtD
Polythiazide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00382	0.00382	CcSEcCtD
Polythiazide—Nausea—Sunitinib—pancreatic cancer	0.00374	0.00374	CcSEcCtD
Polythiazide—Asthenia—Irinotecan—pancreatic cancer	0.00372	0.00372	CcSEcCtD
Polythiazide—Jaundice—Epirubicin—pancreatic cancer	0.00369	0.00369	CcSEcCtD
Polythiazide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00366	0.00366	CcSEcCtD
Polythiazide—Asthenia—Gemcitabine—pancreatic cancer	0.00362	0.00362	CcSEcCtD
Polythiazide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00359	0.00359	CcSEcCtD
Polythiazide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00355	0.00355	CcSEcCtD
Polythiazide—Diarrhoea—Irinotecan—pancreatic cancer	0.00355	0.00355	CcSEcCtD
Polythiazide—Agranulocytosis—Epirubicin—pancreatic cancer	0.00354	0.00354	CcSEcCtD
Polythiazide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00351	0.00351	CcSEcCtD
Polythiazide—Diarrhoea—Gemcitabine—pancreatic cancer	0.00346	0.00346	CcSEcCtD
Polythiazide—Dizziness—Irinotecan—pancreatic cancer	0.00343	0.00343	CcSEcCtD
Polythiazide—Jaundice—Doxorubicin—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Polythiazide—Anorexia—Docetaxel—pancreatic cancer	0.00342	0.00342	CcSEcCtD
Polythiazide—Diarrhoea—Fluorouracil—pancreatic cancer	0.0034	0.0034	CcSEcCtD
Polythiazide—Vomiting—Irinotecan—pancreatic cancer	0.0033	0.0033	CcSEcCtD
Polythiazide—Dizziness—Fluorouracil—pancreatic cancer	0.00328	0.00328	CcSEcCtD
Polythiazide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Polythiazide—Rash—Irinotecan—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Polythiazide—Dermatitis—Irinotecan—pancreatic cancer	0.00327	0.00327	CcSEcCtD
Polythiazide—Headache—Irinotecan—pancreatic cancer	0.00325	0.00325	CcSEcCtD
Polythiazide—Paraesthesia—Docetaxel—pancreatic cancer	0.00322	0.00322	CcSEcCtD
Polythiazide—Vomiting—Gemcitabine—pancreatic cancer	0.00321	0.00321	CcSEcCtD
Polythiazide—Rash—Gemcitabine—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Polythiazide—Dermatitis—Gemcitabine—pancreatic cancer	0.00318	0.00318	CcSEcCtD
Polythiazide—Headache—Gemcitabine—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Polythiazide—Vomiting—Fluorouracil—pancreatic cancer	0.00316	0.00316	CcSEcCtD
Polythiazide—Rash—Fluorouracil—pancreatic cancer	0.00313	0.00313	CcSEcCtD
Polythiazide—Dermatitis—Fluorouracil—pancreatic cancer	0.00313	0.00313	CcSEcCtD
Polythiazide—Decreased appetite—Docetaxel—pancreatic cancer	0.00312	0.00312	CcSEcCtD
Polythiazide—Headache—Fluorouracil—pancreatic cancer	0.00311	0.00311	CcSEcCtD
Polythiazide—Nausea—Irinotecan—pancreatic cancer	0.00308	0.00308	CcSEcCtD
Polythiazide—Constipation—Docetaxel—pancreatic cancer	0.00306	0.00306	CcSEcCtD
Polythiazide—Nausea—Gemcitabine—pancreatic cancer	0.003	0.003	CcSEcCtD
Polythiazide—Nausea—Fluorouracil—pancreatic cancer	0.00295	0.00295	CcSEcCtD
Polythiazide—Muscle spasms—Epirubicin—pancreatic cancer	0.00285	0.00285	CcSEcCtD
Polythiazide—Agitation—Epirubicin—pancreatic cancer	0.00272	0.00272	CcSEcCtD
Polythiazide—Vertigo—Epirubicin—pancreatic cancer	0.00266	0.00266	CcSEcCtD
Polythiazide—Leukopenia—Epirubicin—pancreatic cancer	0.00265	0.00265	CcSEcCtD
Polythiazide—Hypersensitivity—Docetaxel—pancreatic cancer	0.00264	0.00264	CcSEcCtD
Polythiazide—Muscle spasms—Doxorubicin—pancreatic cancer	0.00263	0.00263	CcSEcCtD
Polythiazide—Asthenia—Docetaxel—pancreatic cancer	0.00257	0.00257	CcSEcCtD
Polythiazide—Agitation—Doxorubicin—pancreatic cancer	0.00252	0.00252	CcSEcCtD
Polythiazide—Vertigo—Doxorubicin—pancreatic cancer	0.00246	0.00246	CcSEcCtD
Polythiazide—Leukopenia—Doxorubicin—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Polythiazide—Diarrhoea—Docetaxel—pancreatic cancer	0.00245	0.00245	CcSEcCtD
Polythiazide—Dizziness—Docetaxel—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Polythiazide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00237	0.00237	CcSEcCtD
Polythiazide—Anorexia—Epirubicin—pancreatic cancer	0.0023	0.0023	CcSEcCtD
Polythiazide—Vomiting—Docetaxel—pancreatic cancer	0.00228	0.00228	CcSEcCtD
Polythiazide—Rash—Docetaxel—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Polythiazide—Dermatitis—Docetaxel—pancreatic cancer	0.00226	0.00226	CcSEcCtD
Polythiazide—Headache—Docetaxel—pancreatic cancer	0.00225	0.00225	CcSEcCtD
Polythiazide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00219	0.00219	CcSEcCtD
Polythiazide—Paraesthesia—Epirubicin—pancreatic cancer	0.00217	0.00217	CcSEcCtD
Polythiazide—Anorexia—Doxorubicin—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Polythiazide—Nausea—Docetaxel—pancreatic cancer	0.00213	0.00213	CcSEcCtD
Polythiazide—Decreased appetite—Epirubicin—pancreatic cancer	0.0021	0.0021	CcSEcCtD
Polythiazide—Constipation—Epirubicin—pancreatic cancer	0.00207	0.00207	CcSEcCtD
Polythiazide—Paraesthesia—Doxorubicin—pancreatic cancer	0.00201	0.00201	CcSEcCtD
Polythiazide—Decreased appetite—Doxorubicin—pancreatic cancer	0.00194	0.00194	CcSEcCtD
Polythiazide—Urticaria—Epirubicin—pancreatic cancer	0.00192	0.00192	CcSEcCtD
Polythiazide—Constipation—Doxorubicin—pancreatic cancer	0.00191	0.00191	CcSEcCtD
Polythiazide—Hypersensitivity—Epirubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Polythiazide—Urticaria—Doxorubicin—pancreatic cancer	0.00178	0.00178	CcSEcCtD
Polythiazide—Asthenia—Epirubicin—pancreatic cancer	0.00173	0.00173	CcSEcCtD
Polythiazide—Diarrhoea—Epirubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Polythiazide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00165	0.00165	CcSEcCtD
Polythiazide—Asthenia—Doxorubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Polythiazide—Dizziness—Epirubicin—pancreatic cancer	0.0016	0.0016	CcSEcCtD
Polythiazide—Vomiting—Epirubicin—pancreatic cancer	0.00154	0.00154	CcSEcCtD
Polythiazide—Diarrhoea—Doxorubicin—pancreatic cancer	0.00153	0.00153	CcSEcCtD
Polythiazide—Rash—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Polythiazide—Dermatitis—Epirubicin—pancreatic cancer	0.00152	0.00152	CcSEcCtD
Polythiazide—Headache—Epirubicin—pancreatic cancer	0.00151	0.00151	CcSEcCtD
Polythiazide—Dizziness—Doxorubicin—pancreatic cancer	0.00148	0.00148	CcSEcCtD
Polythiazide—Nausea—Epirubicin—pancreatic cancer	0.00144	0.00144	CcSEcCtD
Polythiazide—Vomiting—Doxorubicin—pancreatic cancer	0.00142	0.00142	CcSEcCtD
Polythiazide—Rash—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Dermatitis—Doxorubicin—pancreatic cancer	0.00141	0.00141	CcSEcCtD
Polythiazide—Headache—Doxorubicin—pancreatic cancer	0.0014	0.0014	CcSEcCtD
Polythiazide—Nausea—Doxorubicin—pancreatic cancer	0.00133	0.00133	CcSEcCtD
